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many RTKs, binding of the cognate ligand leads to receptor dimerization followed by auto-or transphosphorylation on tyrosine residues (Heldin 1995) . This phosphorylation event creates specific docking sites for a variety of cytosolic molecules, such as Src homology 2 (SH2) domain-containing proteins (Cantley et al. 1991; Koch et al. 1991; Cohen et al. 1995) and phosphotyrosine binding (PTB) domain-containing proteins (Blaikie et al. 1994; Kavanaugh and Williams 1994) . Determining the significance and function of receptor-binding events is a key issue in understanding how RTKs transduce such a diverse array of signals. Most studies have addressed this problem by mutating individual RTK phosphorylation (and docking) sites and then assessing the consequences of these mutations on receptor function. Although this 4Corresponding author. approach has provided many insights into the molecular mechanisms of RTK-mediated signaling, most of the biological assays employed are based on tissue culture systems rather than on intact organisms in which the RTK actually functions.
Early Drosophila embryogenesis, and in particular, activation of the Torso (Tor) RTK pathway, provides an attractive in vivo model system with which to study the genetic and molecular mechanisms of RTK signal transduction (for review, see Lu et al. 1993b; Duffy and Perrimon, 1994) . In the developing Drosophila embryo, activation of the Tot RTK leads to the formation of specialized anterior and posterior terminal structures, termed the acron and telson, respectively (for review, see St. Johnston and Nfisslein-Volhard 1992; Duffy and Perrimon 1994) . Although Tor is expressed uniformly throughout the embryo, the protein is activated only in the terminal regions due to the spatially restricted delivery of a diffusible ligand (Casanova and Struhl 1989, 1993; Sprenger and Nfisslein-Volhard 1992) . Once Tor is activated, the further transmission of the terminal structure signal has been shown genetically to involve an evolutionarily conserved cassette of signaling molecules including Drk (a Grb2/Sem-5 homolog), Sos, Rasl, Gapl, D-Raf, D-Mek, Rolled (a MAPK homolog) , and the SH2 domain-containing tyrosine phosphatase Corkscrew (Csw) (for review, see Duffy and Perrimon 1994) . Lossof-function (1-o-f) mutations in the terminal class genes result in a reduction or elimination of terminal structures (i.e., a terminal mutant phenotype). Specifically, in the most severe 1-o-f mutations, the anterior head skeleton is collapsed and all structures posterior to abdominal segment 7 (A7) are deleted. Gain-of-function (g-o-f) mutations in the terminal pathway have also been isolated. These lead to an expansion of the terminal regions, at the expense of the central segmented regions, and the subsequent expression of terminal structures in inappropriate areas of the embryo.
The maternally derived Tor pathway regulates the expression of at least two zygotic gap genes, tailless (tll) and huckebein (hkb) (for review, see Duffy and Perrimon 1994) . These genes, which are expressed in defined terminal domains of the embryo, encode transcription factors that further specify development of the terminal re- In this paper we use a combination of biochemical, molecular, and genetic techniques to study the ability of Tor to propagate a developmental signal in an in vivo, whole organismal setting. Here, we identify two major sites of Tor autophosphorylation, Y630 and Y918, and show that Y630 is essential for interaction with and subsequent phosphorylation of Csw on tyrosine residues. We demonstrate further that the tyrosine phosphorylation of Csw in vivo correlates with the presence of an activated Tot receptor. Finally, by establishing transgenic fly lines expressing only mutant Tor proteins, we provide in vivo evidence that Y630 is a critical residue involved in the positive transduction of the Tor signal, that Y918 functions as a negative regulator, and that mutation of both of these sites in concert compensates or balances one another.
Results

Identification of Tor autophosphorylation sites
The auto-or transphosphorylation of receptor molecules on tyrosine residues provides an important mechanism whereby mammalian RTKs interact with downstream effector proteins. Therefore, to gain a better understanding of how Tor transduces a signal, we performed experiments to determine the sites of Tor autophosphorylation. For this analysis, immunoprecipitated Tor proteins were washed extensively and allowed to autophosphorylate in vitro in the presence of Mn 2+ and [~/-32p]ATP. Wild-type Tor (Tor wT) proteins subjected to this treatment were phosphorylated exclusively on tyrosine residues; however, kinase-inactive Tor (TKM) did not become phosphorylated, indicating that the immunoprecipitates did not contain contaminating kinases capable of phosphorylating Tor (Sprenger et al. 1993 ). 3~p-Labeled Tor wT was electrophoresed on SDS-polyacrylamide gels, isolated from the gel matrix, and digested with trypsin. The tryptic phosphopeptides were then separated and eluted from a reverse-phase HPLC C-18 column. When the radioactivity released from the column was quantitated, two major peaks, eluting in fractions 13 and 28, were detected (Fig. 1A) . Phosphoamino acid analysis of the peptides contained in these fractions indicated that they were phosphorylated exclusively on tyrosine (data not shown). By subjecting the peptides to automated Edman degradation, we determined that the peptide isolated in fraction 13 was phosphorylated on the fourth residue following the trypsin cleavage site (Fig.  1B) and that the peptide in fraction 28 was phosphorylated on the eleventh residue (Fig. 1C) . When 32p-labeled Tot wT was digested with the proteolytic enzyme LysC (which cleaves only after lysine residues, as opposed to trypsin, which cleaves after lysine and arginine residues), similar peaks and sequence data were obtained (data not shown). To ensure that the identified sites represent activated Tor autophosphorylation sites, these experiments were repeated using the g-o-f Tor 4~ protein. The results obtained demonstrated that activated Tor 4~ autophosphorylates at the same sites and to the same degree as Tor wT (data not shown). Furthermore, no additional sites of phosphorylation were observed on the Tor 4~ protein (data not shown). From this analysis we conclude that Y630 and Y918 are the sites of phosphorylation, because these are the only tyrosine residues in Tor that are 4 and 11 residues downstream from a trypsin and LysC cleavage site, respectively.
To confirm the identification of these tyrosine residues, we generated mutant Tor proteins that contained tyrosine to phenylalanine substitutions at amino acid positions 630 (Y630F), 918 (Yg18F), and 630/918 (YY630/ 918FF). The mutant proteins were then autophosphorylated in vitro, and the phosphorylated tryptic peptides were examined by reverse-phase HPLC. The profile of the radioactivity released during this analysis revealed that Tor Y630F contained one major phosphorylated peptide that eluted in fraction 28 (Fig. 1D) . In contrast, a peak of radioactivity was not released at fraction 28 for Tor Y918F, but a major peak was detected in fraction 13 (Fig. 1E) . When Tot YY630/918FF was examined, both major peaks at fractions 13 and 28 were missing (Fig. IF) . These data confirm that Y630 and Y918 are the major autophosphorylation sites of Tor and indicate further that the mutant Tor proteins are functional kinases in vitro. In addition, this analysis demonstrates that phosphorylation of Y630 and Y918 is not interdependent and that mutation of these sites does not induce the aberrant phosphorylation of other sites. (Cantley et al. 1991; Koch et al. 1991; Cohen et al. 1995 (Fig. 2) . Both mammalian PLC~ and GAP were also able to associate with activated Tor wT but not with TKM or proteins containing the Y918F mutation (Fig. 2 ). In contrast, Drk, the Drosophila homolog of Grb2, did not interact with any of the Tor receptors (Fig. 2) . Together, these results indicate that activated, autophosphorylated Tor can bind Csw, PLC% and GAP. The association with Figure 2 . Association of Tor mutants with various SH2 domain-containing proteins. In vitro binding assays were performed using the various Tor mutants and lysates containing Csw, PLC% GAP, and a glutathione S-transferase/Drk fusion protein (GST-Drk). Proteins associating with the Tor receptors were detected by immunoblot analysis using antibodies recognizing Csw (~Csw), GST (~GST), PLC-/ (~PLC~/), and GAP (~GAP). The Tor immunoprecipitates were subsequently reprobed with Tor antibodies (~Tor). Samples of the lysates used are included as a control. The Tor mutants examined in this study include kinase-inactive TKM, Tor wT (WT), and Tor proteins containing tyrosine to phenylalanine substitutions at amino acids 630 (Y630F), 918 (Y918F), and 630/918 (YY630/ 918FF).
Csw, however, requires the Y630 site, whereas the interaction with PLC,/and GAP requires Y918. Although the significance of the association of mammalian PLC~ and GAP is unclear, Csw is involved in terminal structure development and has been shown genetically to function downstream of Tor (Perkins et al. 1992) .
Csw is a substrate of the Tor RTK
Because Csw is a component of the Tor signaling pathway and associates with the activated Tor receptor, we then investigated whether Csw becomes tyrosine phosphorylated as a result of this interaction. For this analysis, we examined the phosphorylation state of Csw coexpressed in Sf9 cells with the various Tor mutants. In addition, because the ligand for Tor is unknown and authentic ligand-induced activation of the receptor is not possible, all tyrosine mutations were incorporated into the constitutively activated g-o-f Tor 4~ protein. By immunoblot analysis using antiphosphotyrosine (oLP-Tyr) antibodies, Csw was found to be phosphorylated on tyrosine residues when coexpressed with activated Tor 4~ proteins, but only when the receptor contained the Y630 site (Fig. 3) . Mutation of the Y630 site did not simply inactivate the in vivo kinase activity of Tot, because the tyrosine phosphorylation of GAP could be induced following coexpression of GAP with the Y630F mutant ( Fig.  3) . Thus, these findings suggest that the association with Tor results in the tyrosine phosphorylation of Csw and that Csw is a substrate of Tor.
To determine whether Csw becomes tyrosine phosphorylated as a direct result of Tor ligand-induced activation, we coexpressed Csw with a chimeric Tor receptor containing the extracellular domain of the mammalian Trk /nerve growth factor (NGF) receptor. As controls, Csw was also coexpressed with the constitutively activated Tor 4~ protein and with the wild-type Trk receptor. Cells were then treated with NGF, and the phosphorylation state of Csw was examined. By immunoblot analysis, treatment with NGF had no effect on the level of tyrosine phosphorylation observed when Csw was coexpressed with activated Tot 4~ (Fig. 4) . Consistent with the observation that SH-PTP2/Syp, the mammalian homolog of Csw, is not a substrate of the Trk receptor (Vambutas et al. 1996) , activation of Trk with NGF treatment did not alter the phosphorylation state of Csw (Fig. 4) . However, NGF treatment did induce the tyrosine phosphorylation of Csw in cells coexpressing the chimeric Trk-Tor receptor (Fig. 4) , demonstrating that ligand-induced activation of the chimeric receptor results in the phosphorylation of Csw on tyrosine residues.
Tyrosine phosphorylation of C s w in Drosophila embryos
To determine whether Csw is tyrosine phosphorylated in vivo and whether its phosphorylation state correlates with Tor activation, we examined the phosphorylation state of Csw in developing Drosophila embryos. Previously, we showed that Tor wT is expressed 0-4 hr after egg laying (at 27~ and that it becomes tyrosine phosphorylated and activated 1-2 hr after egg laying (Sprenger et al. 1993) . In contrast, 1-o-f Tor proteins are not tyrosine phosphorylated in vivo and lack kinase activity, whereas g-o-f Tor proteins are constitutively tyrosine phosphorylated and activated (Sprenger et al. 1993) . Therefore, for this analysis, we examined the tyrosine phosphorylation state of Csw isolated from embryos derived from females homozygous for the 1-o-f tor wK and g-o-f tor 4~ mutations. Csw proteins were immunopre- cipitated from embryos collected at 0--3 and 12-24 hr after egg laying and examined by immunoblot analysis using ~P-Tyr antibodies. The tyrosine phosphorylation of Csw was observed only in tor 4~ embryos and only at the time of Tor expression (0-3 hr) (Fig. 5) . In addition, the tyrosine phosphorylation of Csw was found to be coincident with the tyrosine phosphorylation of the g-o-f Tor 4~ protein (Fig. 5) . These results indicate that Csw is tyrosine phosphorylated in vivo and that its phosphorylation state correlates with the expression of an activated Tor protein.
In vivo function of Y630 and Y918
To determine the roles of the Y630 and Y918 autophosphorylation sites in Tor-mediated signal transduction, we examined in vivo the signaling activities associated with the corresponding tor mutants. For this analysis, the Y630F and Y918F mutations were incorporated into an 11.5-kb tor + genomic fragment that fully rescues tor 1-o-f mutations (see Materials and methods). To eliminate completely other sources of Tor expression, the Tor mutant receptors were expressed in the background of tO1AcR1, a protein null allele (Sprenger et al. 1989 (Sprenger et al. , 1993 . The signaling abilities of the Tor mutant proteins were then determined by measuring the spatial expression domains of tll and h k b and by examining the embryonic cuticles. In these studies the control T o r w T (P[tor+]) fully rescued the terminal phenotypes associated with tor TM (Table 1 ). In addition, as was observed previously by Casanova and Struhl (1989) , the amount of Tot in wild-type embryos appeared to greatly exceed the level needed for terminal cell fate specification in that decreasing the copy number of P[tor +] did not affect the expression of tll and hkb. Examination of embryos derived from females that expressed P[tor Y63~ revealed that Y630 was involved in the positive transmission of the Tor signal. As shown in Table 1 , expression of this mutant allele decreased the domain of tll expression by 15.6% (reduced to 12.45% EL in T o r u176 from 14.75% in wild type; Fig. 6C ) and h k b expression by 31% (reduced to 5.7% EL in T o r Y63~ from 8.25% in wild type; Fig. 6D ). Furthermore, the embryonic cuticle phenotype resembled a 1-o-f function terminal phenotype (Fig. 7C) .
The Y918 site, however, appeared to act as a negative regulator of Tor signaling. As indicated in Table 1 , embryos derived from females that carried two copies of P[tor Y918F] showed a clear expansion of the expression domains of both tll (by 19%; Fig. 6E ) and h k b (by 11.5%; Fig. 6F ). Expansion of the expression domain of the terminal gap genes toward the center of the embryo was shown previously to be associated with the repression of abdominal segmentation (Steingrimsson et al. 1991) .
Therefore, as expected, embryos derived from P [tor Y918F] females contained abdominal segment defects that were reminiscent of those associated with tor g-o-f mutations ( Fig. 7D-F ; for review, see Duffy and Perrimon 1994). Interestingly, the ectopic expression of both tll and h k b was less pronounced in the presence of a single copy of P[tor Y918F] (see Table 1 ), an effect most likely attributable to the difference in the amount of activated receptor present in the embryo.
To determine the effect of removing both a positive and negative signaling site from the Tot receptor, we generated a transgene that contained the YY630/918FF double mutation. As shown in Table 1 , mutation of both sites appeared to compensate for one another, because the expression domains of both tll and h k b were similar to those of wild type. This finding was observed regardless of whether the transgenic lines expressed one or two copies of P[torYY63~
In addition, when the embryonic cuticle phenotype was examined, the cuticle structures of the tor Yv63~ embryos resembled that of wild type. From this analysis, the only difference detected between tot YY63~
and tor wT embryos was in the percentage of animals that reached adulthood, which embyros was reduced by 55% (data not shown). Together, these results indicate that receptors containing the YY630/918FF mutations are comparable to wild type in Tor signaling.
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D i s c u s s i o n
In this study we have examined the contribution of individual sites of tyrosine phosphorylation in regulating the ability of the Tot RTK to transduce a developmental signal. By protein sequencing techniques, we identified two major sites of autophosphorylation, Y630 and Y918 (Fig. 1) . Y630 is located within the kinase insert region of the Tor receptor, whereas Y918 lies near the carboxyl terminus. Both sites were found to be crucial for the correct specification of terminal cell fate in developing Drosophila embryos. One site, Y630, serves to positively transduce the Tor signal, whereas the second site, Y918, functions as a negative effector. Elimination of both sites, however, had a compensating effect, restoring to a Figure 5 . Csw is tyrosine phosphorylated in Tot g-o-f but not 1-o-f embryos. Embryos expressing 1-o-f tor wK and g-o-f tor ~~ alleles were collected at various times after egg laying, and lysates were prepared. Csw (A) and Tot (B) proteins were immunoprecipitated from the lysates and examined by immunoblot analysis using ~P-Tyr antibodies. large degree the imbalance resulting from the individual mutations.
C s w associates with Y630 to positively transduce the Tor signal
Our studies indicate that Y630 functions in the positive transmission of the Tor signal. Embryos expressing T o t Y63~ proteins exhibited an 1-o-f terminal phenotype that included a reduction in the posterior expression of both tll and h k b and a corresponding reduction in cuticular elements. The Y630F mutation impairs but does not completely block Tor signaling, because in tor null mutants there is a complete lack of tll and h k b expression posteriorly (Weigel et al. 1990; Pignoni et al. 1992; Lu et al. 1993b) . Thus, there must be at least one other region on Tor, in addition to Y630, that serves to positively transduce the Tor signal.
How does Y630 exert its influence? For m a n y RTKs, autophosphorylation sites in noncatalytic regions function as docking sites for a variety of cytosolic signaling molecules that contain SH2 (Cantley et al. 1991; Koch et al. 1991; Cohen et al. 1995) or PTB (Blaikie et al. 1994; Kavanaugh and Williams 1994) domains. Given the precedent in m a m m a l i a n systems, Y630 and Y918 would be expected to serve as binding sites for downstream signaling molecules involved in terminal structure development. All of our findings suggest that Y630 functions as a binding site for the SH2 domain-containing, nonreceptor protein tyrosine phosphatase Csw and that Csw m a y be a substrate of Tor. In vitro binding studies showed that Csw could associate with activated tyrosine phosphorylated Tot receptors but only when Y630 was present. Using the baculovirus/Sf9 expression system, we found that Csw was tyrosine phosphorylated when coexpressed with activated g-o-f Tor proteins containing Y630. In addition, by using a chimeric Trk-Tor receptor, we were able to show that Csw was phosphorylated following ligand-induced activation of Tor. These results appear to reflect in vivo signaling events, because Csw immunoprecipitated from developing Drosophila em- (no.) N u m b e r of embryos scored in each experiment. The domain of expression of both tll and hkb was determined as the percentage of egg length (EL) and the standard deviation (S.E.M.) for each sample size is indicated. The hatching rates were determined as the n u m b e r of hatching larvae divided by the total number of fertilized eggs. A fraction of the tot Y63~ animals was able to hatch from the egg case and give rise to viable adults. These were most likely derived from the embryos that showed the less severe reduction in both tll and hkb expression.
bryos was tyrosine phosphorylated when expressed with an activated but not an inactive form of the Tot kinase.
Results examining transgenic flies are also consistent with Y630 functioning as a docking site for Csw. Csw has been identified by genetic studies as a positive transducer of the terminal pathway acting downstream of Tor (Perkins et al. 1992 ). If Y630 is the Csw docking site, then elimination of this residue would be expected to produce a phenotype similar to that resulting from the Figure 6 . Effect of the tor phosphotyrosine m u t a n t s on the expression of tll and hkb. Ex (E,F) . The domains of tll and hkb expression indicates as percentage of egg length {EL/, with 0% corresponding to the posterior pole. The reduction in the domains of expression of both tlI and hkb associated with tor Y63~ reveals that this tyrosine is required for positive signaling from Tot. The increase in the domains of expression of both tll and hkb associated with tor Y918F demonstrates that this tyrosine is critical for down-regulating the activity of Tor. 
loss of Csw protein. This is indeed the case; however, the domain of expression of the terminal g a p genes is not as severely affected in t o r Y6$~ embryos as in c s w mutant animals. This discrepancy in severity of phenotypes could be accounted for by the ability of Csw to interact indirectly with the Tot receptor at other sites. Altematively, it is possible that the genetically null c s w mutants examined previously (Perkins et al. 1992) do not correspond to protein null mutations and that dominant-
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P[torY918F]; torXa~/torXR1 (D-F).
In the tor T M 1-o-f phenotype (B), embryos show defects both anteriorly and posteriorly. In these embryos, the labrum, A8, and telson are missing and the head skeleton is collapsed. Embryos derived from tor T M females that carry one or two copies of P[tor Y63~ partially rescue the tor terminal defects. In the embryo shown in C, the defects are associated with the head skeleton and the partial rescue of A8. No differences in the embryonic phenotypes are detected, regardless of whether the females carry one or two copies of P[torY63~ Embryos derived from tor T M females that carry one or two copies of P[tor Y918~] exhibit a tor g-o-f phenotype (D-F). These embryos are associated with different degrees of deletion of the abdominal segments, and the extent of the defects is stronger with two copies of the P element. Abbreviations: (A7 and A8) the positions of the abdominal 7 and 8 segments, respectively; (fk)Filzk6rper; (at) anal tuft. negative effects, which would further reduce the signaling activity of Tor, could be associated with these mutant Csw proteins.
The direct association of Csw with activated Tor is similar to results reported for the vertebrate homologs of Csw, SH-PTP2/Syp. Like Csw, the vertebrate homologs have been shown to associate with a variety of activated RTKs to positively transduce RTK-mediated signals Milarski and Saltiel 1994; Noguchi et al. 1994; Xiao et al. 1994; Tang et al. 1995) , and in certain instances, they become phosphorylated on tyrosine in response to RTK activation (Feng et al. 1993; Vogel et al. 1993) . As with the vertebrate homologs, the actual m e c h a n i s m of Csw action is unclear. Catalytic activity appears necessary for both Csw and SH-PTP2/Syp to transduce developmental signals in Drosophila and Xenopus, respectively (L.A. Perkins, unpubl.; Tang et al. 1995) . No substrates for these phosphatases have been identified in Drosophila or Xenopus, although in a recent report the m a m m a l i a n PDGF ~-receptor was identified as a putative substrate of SH-PTP2/ Syp (Klinghoffer and Kazlauskas 1995) . Similarly, the function of Csw tyrosine phosphorylation remains ambiguous. In one report phosphory!ation appeared to have a modest activating effect on the catalytic activity of SH-PTP2/Syp (Vogel et al. 1993) , whereas in a second report phosphorylation had no effect (Feng et al. 1993) . Furthermore, elimination of the two known phosphorylation sites in the carboxy-terminal tail of SH-PTP2/Syp (one of which is conserved in Csw} had no observable effect on the ability of the protein to propagate a fibroblast growth factor (FGF)-mediated signal in Xenopus development (Tang et al. 1995 ). An alternative function for Csw tyrosine phosphorylation may be to allow Csw to function as an adaptor protein linking the Tor signal to Ras activation. Ras activation by m a n y RTKs involves the binding of a Grb2(Drk)-Sos complex to an autophosphorylated YXNX motif within the RTK (Songyang et al. 1993) . The platelet-derived growth factor (PDGF) receptor activates Ras, in part, through an interaction with SH-PTP2/Syp, which contains several YXNX sequences (Bennett et al. 1994; Li et al. 1994 with Tor. However, one of the YXNX motif phosphorylation sites identified in SH-PTP2/Syp (Bennett et al. 1994 ) is a conserved site of phosphorylation in Csw (V. Cleghon and D.K. Morrison, unpubl.), indicating that Csw may also function as an adaptor protein linking Tor signaling to Ras activation. Consistent with this model, previous studies have implicated Ras activation as an important component in the terminal pathway (Lu et al. 1993a ). In addition, Drk mutant embryos (Hou et al. 1995 ) display 1-o-f terminal phenotypes that resemble those of both csw null and tor v63~ mutants. Taken together, our evidence suggests strongly that Y630 functions as a positive transducer of the Tor signal and that this effect is mediated by the binding of Csw. Furthermore, our results support the model linking Csw with Ras activation.
The role of Y918 as a negative effector of the Tor signal
Y918 appears to be a negative effector of the terminal pathway. Embryos expressing Tor u display a g-o-f terminal phenotype that is characterized by expanded tll and hkb expression posteriorly and increased terminal cuticular structures. What is the nature of the Y918 negative effector? All available information suggests that Y918 functions as a binding site for downstream signaling molecules. Of the two SH2 domain-containing proteins that have been shown to function in the terminal pathway, Csw (Perkins et al. 1992) and Drk (Hou et al. 1995) , neither associates with the Y918 site. However, our experiments did show that Y918 could serve as a specific binding site for the mammalian signaling proteins PLC7 and GAP. In addition, both mammalian proteins were phosphorylated on tyrosine when coexpressed in Sf9 cells with kinase-active Tor containing Y918 ( Fig.  3 ; data not shown). From these findings, we postulate that the Drosophila counterparts of these proteins may be involved in the Tor signaling pathway. A Drosophila PLC7 homolog containing two tandem SH2 domains was recently described (Emori et al. 1994) , although no 1-o-f phenotype has been attributed to this protein. In mammalian signaling pathways, PLC7 typically functions in the positive transmission of RTK signals; however, there is a precedent for GAP to function as a negative effector. In an analysis of substrate-binding sites on the murine PDGF receptor, the GAP-binding site suppressed PDGF-induced mitogenesis (Valius et al. 1995) . One function of GAP is to stimulate the endogenous GTPase activity of Ras, thereby regulating the level of active GTP-bound Ras and inactive GDP-bound Ras (Boguski and McCormick 1993) . Therefore, the association of a Drosophila GAP would provide a model whereby Y918 could function as a negative regulator by limiting Ras activation. A Drosophila homolog of GAP, Gapl (Gaul et al. 1992) , has been implicated genetically to be involved in the Tor pathway (Hou et al. 1995) . Inactivation of the Gapl locus in germ-line mosaics results in embryos exhibiting a g-o-f phenotype similar in severity to that of the tor Yg~SF mutant. Although Gapl is an attractive candidate for the negative effector that binds to Y918, this protein, unlike the mammalian homolog used in our studies, does not contain an SH2 domain (Gaul et al. 1992) ; therefore, direct binding of Gapl to Y918 seems unlikely. However, an SH2 domain-containing adaptor molecule could conceivably link Gap l to Tot, just as Drk links Sos to RTK-mediated activation of Ras. Alternatively, other Drosophila GAP proteins, in addition to Gap l, may exist that do contain SH2 domains. Finally, our studies do not rule out the possibility that other, as yet unidentified, proteins bind at the Y918 site and serve as negative effectors of the Tot signal.
Compensating effect of Y630 and Y918
Perhaps most intriguing of all is our finding that mutation of both major autophosphorylation sites results in near-wild-type patterns of tll and hkb posterior expression and apparently normal terminal cuticular structures. Clearly, alteration of either Y630 or Y918 individually has a profound effect on the ability of Tor to transmit a terminal signal. However, removal of the positive effector site, Y630, in conjunction with the simultaneous removal of Y918, does not block transduction of the Tor signal. Therefore, at least one additional positive pathway for Tot signal transmission, which does not depend on the binding of substrates to the Y630 and Y918 sites, must exist. The increased strength of the positive signal transmitted by the Tot YY63~ mutant compared with the Tor Y63~ mutant substantiates further the existence of another underlying and as yet unidentified receptor-activated pathway. Such a pathway may be initiated by substrate recognition of unique receptor sequences or of minor autophosphorylation sites. Whereas Y630 and Y918 represent the major sites of tyrosine phosphorylation, our mapping studies indicate that additional minor sites do exist and are qualitatively and quantitatively unaltered in all of our Tot phosphorylation site mutants (see Fig. 1 ). However, the lower levels of phosphorylation may not reflect the contribution that these sites make to the propagation of the Tor signal, because little is known concerning the stoichiometry of phosphorylation and the relative affinities of cytosolic signaling molecules for their binding sites in vivo. It is therefore quite possible that minor phosphorylation sites also play a role in the positive transmission of the Tor signal and that the influence of the minor sites could expand once the major phosphorylation sites are removed.
The compensating effect of the YY630/918FF mutation in restoring near-wild-type development is consistent with a model in which the Y630 and Y918 sites serve as a single control element that is comprised of both positive and negative effectors of the Ras 1 pathway and that functions in addition to another, as yet unidentified, receptor-activated pathway. In this scenario, Csw binding to the Y630 site would represent the positive effector linking Tor activation to Ras activation through the binding of Drk and Sos, whereas a GAP protein binding to the Y918 site would provide negative regulation by attenuating Ras activity. Perturbing the control element by removing either the positive or negative regulatory element would result in the delivery of too much or too little signal. However, removing the entire regulatory element would leave the main signaling sequence intact and capable of delivering a normal signal. The elaboration of the Tor signaling complex by the addition of positive and negative regulatory elements may provide an important mechanism whereby the delivery of the terminal signal can be modulated precisely.
In conclusion, our results indicate that the Tor receptor contains phosphotyrosine residues that function in the positive and negative transmission of the Tor signal. These sites appear to exert their influence by binding to specific downstream effector molecules. These findings demonstrate that the delivery of a balanced signal is crucial for proper terminal structure development and emphasize further that it is not only the effectors themselves that are important but also the timing and particular mix of Tor-associated proteins that determine the efficacy of the signal.
Materials and methods
Antibodies
The Tot antibody is a rabbit polyclonal antibody directed against the cytoplasmic domain of Tor (Sprenger et al. 1993) . The Csw antibody is a rabbit polyclonal antibody generated against a purified synthetic peptide corresponding to amino acid residues 423-440 of Csw. The PLC7 antibody is a murine monoclonal antibody (Suh et al. 1988} . The GAP antibody was generated by immunizing rabbits with a bacterial fusion protein containing amino acid residues 171-448 of human GAP (Upstate Biotechnology Incorporated).
Construction of mutant Tor proteins and generation of recom binan t baculoviruses
cDNA clones encoding tor wT and tor ~~ alleles (pBtor, pB4021, respectively; Sprenger et al. 1993) were digested with BamHI and EcoRI. Fragments containing the entire Tor coding sequences were inserted into the NcoI-EcoRI cloning sites of the pGem-7Zf (Promega) plasmid. Tor constructs encoding amino acid point mutations were generated by site-directed mutagenesis as described previously (Fabian et al. 1993) , using pGemTor and the appropriate oligonucleotides to introduce the desired base changes. The specific base changes in all mutant constructs were confirmed by sequence analysis, cDNA fragments encoding the entire wild-type and mutant Tor proteins were isolated and inserted into the pAcC4 baculoviral transfer vector for expression in Sf9 cells. For generation of the Csw-expressing baculovirus, BamHI linkers were first inserted into the wildtype Csw cDNA clone (Perkins et al. 1992 ) immediately upstream of the initiating ATG codon and downstream of the TGA terminator codon. The BamHI fragment encoding the Csw protein was then cloned into the pVL941 baculoviral transfer vector for expression in Sf9 cells.
Expression of recombinant Tor proteins, preparation of cellular lysates, and immunoprecipitation assays
Routinely, for recombinant protein production, 2 x 106 Sf9 cells were infected with the desired baculovirus at a multiplicity of infection of 10. At 48 hr postinfection, Sf9 cells were washed twice with ice-cold phosphate-buffered saline (PBS) and lysed for 20 min at 4~ in 500 ~1 of Nonidet P-40 (NP-40) lysis buffer containing 20 mM Tris (pH 8.0), 137 mM NaC1, 10% glycerol, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, aprotinin (0.15 U/ml), 90 p~M leupeptin, and 5 mM sodium vanadate. Insoluble material was removed by centrifugation at 4~ for 10 min at 10,000g, and cell lysates were equalized for Tor protein expression by immunoblot analysis. For Drosophila embryo extracts, flies were grown and collected as described previously (Sprenger et al. 1993) . A 0.05-gram aliquot of the collected embryos was then resuspended in 1 ml of NP-40 lysis buffer, homogenized with six strokes in a ground-glass dounce homogenizer (Wheaton), and incubated on ice for 15 min. Insoluble material was removed from the lysates as described above. Immunoprecipitation assays were performed by incubating lysates with the appropriate antibody for 3 hr at 4~ Protein A/G beads (Santa Cruz Biotechnology, Inc.) were used to collect the antigen-antibody complexes. The immunoprecipitates were then washed four times with cold lysis buffer before analysis.
In vitro kinase assays and phosphoamino acid analysis
Tor immunoprecipitates were washed three times with NP-40 lysis buffer containing 1 mM sodium vanadate and once with kinase buffer [30 mM HEPES at pH 7.4, 10 mM MnCI~, 5 mM MgCI~, 1 mM dithiothreiotol (DTT), 5 ~M ATP]. The complexes were then incubated at 25~ for 15 min in 40 ~1 of kinase buffer containing 20 ~Ci of [7-32p] ATP. Kinase assays were terminated by the addition of gel loading buffer (4% SDS, 80 mM DTT, 10% glycerol), the samples were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and the phosphoproteins were visualized by autoradiography. For phosphoamino acid analysis, labeled proteins were transferred to Immobilon membranes after electrophoresis, visualized by autoradiography, excised, and hydrolyzed directly with 5.7 N HC1 for 70 min at ll0~ The recovered phosphoamino acids were analyzed at pH 1.9 and pH 3.5.
Reverse-phase HPLC
32p-Labeled proteins were separated by SDS-PAGE, eluted from the gel matrix, precipitated with trichloroacetic acid, and digested with trypsin or LysC. Aliquots of the digested proteins were lowered to pH 2.0 with 20% trifluoroacetic acid (TFA) and loaded onto a Waters 3.9x300 mm C18 column. The chromatography was performed in an LKB chromatography system with two 2150 HPLC pumps, a 2152 LC controller, and a 2140 rapid spectral detector. When buffer salts began to elute, the column was developed with an increasing gradient of acetonitrile in 0.05% aqueous TFA. The stepwise gradient at a flow rate of 1 ml/min was 0%-40% CH3CN over 60 min, 40% CH3CN for 10 min, 40%-60% CH3CN over 10 min, and 60% CH3CN for 10 min. Fractions were collected at 1-min intervals, and Cerenkov counted for 32p radioactivity in a Beckman LS 5801 scintillation counter.
Edman degradation
Semiautomated amino-terminal sequence analysis was performed in a Beckman 890C spinning cup sequencer. Polybrene (2.5 mg, Aldrich) was applied to the spinning cup along with 120 nmoles of the dipeptide Tyr-Glu and subjected to four cycles of Edman degradation. Equine apomyoglobin (9 nmoles) along with the 32p-containing peptide in CHgCN-water was then added to the spinning cup, dried, and subjected to 20 cycles with no prewashes. Aliquots of the butyl chloride solutions of the amino acid thiazoline derivatives in cycles 2 and 11 were removed to monitor the sequencing of the apomyoglobin. The
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In vitro association assays
Tor proteins were expressed in Sf9 cells and immunoprecipitared as described above. The immunopreciptated Tot proteins were washed twice with NP-40 lysis buffer containing 0.1% SDS and 0.5% deoxycholate, twice with NP-40 lysis buffer, and twice with 10 mM Tris (pH 7.4). Complexes were then incubated with 30 mM HEPES at pH 7.4, 10 mM MnCla, 1 mM DTT, 100 ~xM ATP, and 200 ~XM sodium vanadate for 30 rain at 25~ Following the kinase reaction, the immunoprecipitates were incubated for 2 hr at 4~ with lysates prepared from cells lysed in NP-40 lysis buffer. The complexes were then washed three times with NP-40 lysis buffer and once with 10 mM Tris (pH 7.4) before immunoblot analysis.
Generation of transgenic flies
The pGem Tot cDNAs encoding either the wild-type or mutant Tor proteins (Y630F, Y918F, YY630/918FF) were used to generate various P-element transformants. The XmnI-AseI fragment of the cDNAs was cloned into the 11.5-kb EcoRI-EcoRI genomic tor DNA, which was shown previously to fully rescue the tor null phenotype (Casanova and Struhl 1989) . The constructs were then cloned into CasPeR4, which contains the marker mini-white (C.S. Thummel, pers. comm.; Thummel et al. 1988 ). P-dement-mediated transformation was performed according to Spradling (1986) following injection into the delta2.3 transposase strain (Robertson et al. 1988) . Transformant lines with insertions on the X chromosome were used to generate flies that carry one or two copies of the P[tor § construct in a tor TM background. Similar results were obtained with multiple independent transformant lines (data not shown), tot TM contains a deletion within the tor gene and does not produce RNA or protein (Sprenger et al. 1989 (Sprenger et al. , 1993 .
Examination of embryos
Embryos were collected at 0--3 hr and prepared for in situ hybridization using digoxygenin-labeled probes as described by Tautz and Pfeifle (1989) . Single-stranded sense and antisense digoxigenin-containing DNA probes were prepared by the polymerase chain reaction labeling technique using appropriate primers (Biolabs). Probes were prepared from plasmids containing the tll (Pignoni et al. 1990 ) and hkb (Weigel et al. 1990) cDNAs. For visualization, embryos were mounted in glycerol. Subsequently, embryos were analyzed and photographed with a Zeiss Axiophot microscope equipped with Nomarski optics. Embryonic cuticles were prepared in Hoyer's mountant as described by van der Meer (1977) from 24-to 36-hr-old embryos.
